To this end, we measured central venous and systemic arterial ET-1 levels in COVID-19 ARDS patients to investigate whether the elevated circulating ΕΤ-1 levels previously reported are related to abnormal ET-1 clearance or net synthesis. The gene discussed is EDN1; the disease is COVID-19.